Patient safety


Access to treatments could reduce post-Brexit

UK patients are at risk of missing out on new treatments after Brexit if a deal is not struck, experts have warned.

Speaking at a Health Committee inquiry yesterday, Dr Jane Spink, chief executive of Genetic Alliance UK, cautioned that if the UK is unable to secure access to European research funding and collaboration as part of the Brexit negotiations, access to trials and medicines for rare diseases in the UK would likely reduce.

Having access to pan-Europeans trials, particularly in the context of a rare diseases, is really critically important because in many rare diseases there are no existing treatments, or existing treatments may be suboptimal,” she explained.

“For a large proportion of rare diseases, the conditions are degenerative, so your ability to access medicines early, even be that through a clinical trial, is incredibly important to patients with rare diseases.

“The least desirable scenario would be for trials to be ongoing in Europe to which UK patients have no access, and then to see products licensed in Europe to which UK patients have no access or delayed access.”

Aisling Burnand MBE, chief executive of the Association of Medical Research Charities, expressed concerns as to where the funding for research in the UK would come from post-2020.

In an ideal Brexit scenario, she said that patients would continue to have fast access to treatments and that there should be continued alignment and collaboration with EU member states.

Currently patients in countries such as Canada, Australia and Switzerland suffer delays of six to 12 months to access new treatments, which Burnand warned must be minimised in the UK.

She also explained that it is important that the UK continues to collaborate with experts across the EU, and for the UK’s young talent to be able to work with these experts and bring knowledge back to the country.

Dr. Beth Thompson, head of UK and EU policy at the Wellcome Trust, was optimistic that a positive agreement should be achievable because of the “mutual benefits.”

However, she warned that a ‘no deal’ Brexit would be extremely challenging because of funding, movement of people and regulatory alignment.

“If political will is there, we should be able to reach a good agreement,” Thompson concluded.

In August, the Brexit Health Alliance listed access to new medicines and healthcare research as some of the top issues in negotiations with Brussels, with NHS Confederation boss Niall Dickson arguing patients “stand to lose out” if these areas aren’t prioritised.

Have you got a story to tell? Would you like to become an NHE columnist? If so, click here.


Eric Nicholls   13/12/2017 at 22:52

Please encourage the re-establishment of close working relationships and collaborations with North America and those Commonwealth countries that strongly supported the Health Service for decades until 20 years ago when they were discouraged and people from the Continent were favoured. Don't despair and don't forget those from other nations that have done far more for the UK and for far longer than any and all of the EU countries.

Add your comment


national health executive tv

more videos >

latest healthcare news

NHS wins landmark drug ruling which could save millions of pounds

21/09/2018NHS wins landmark drug ruling which could save millions of pounds

The NHS has won a landmark legal battle which could save the health service “hundreds of millions a year” after defeating two interna... more >
Partnership forged between pharma body and academic health network in new five-year deal

21/09/2018Partnership forged between pharma body and academic health network in new five-year deal

A new five-year partnership aimed at accelerating the introduction and uptake of transformative biomedical innovations in the NHS has been agreed... more >
Trust chief executive resigns amidst infanticide investigation

21/09/2018Trust chief executive resigns amidst infanticide investigation

The chief executive of the Countess of Chester Hospital FT (COCH) has resigned amid an ongoing police investigation into eight baby deaths in its... more >

editor's comment

25/09/2017A hotbed of innovation

This edition of NHE comes hot on the heels of this year’s NHS Expo which, once again, proved to be a huge success at Manchester Central. A number of announcements were made during the event, with the health secretary naming the second wave of NHS digital pioneers, or ‘fast followers’, which follow the initial global digital e... read more >

last word

Hard to be optimistic

Hard to be optimistic

Rachel Power, chief executive of the Patients Association, warns that we must be realistic about the very real effects of continued underfunding across the health service. It’s now bey... more > more last word articles >

the scalpel's daily blog

Lord Darzi: Seize the opportunity

19/09/2018Lord Darzi: Seize the opportunity

Professor the Lord Darzi of Denham is the Paul Hamlyn chair of surgery at Imperial College, a surgeon working in the NHS and, from 2007-09, was health minister under Labour. Here, he highlights the importance of innovation in the NHS, and the exciting prospects it might bring if we’re brave enough to seize the opportunities ahead. S... more >
read more blog posts from 'the scalpel' >


The Hospital Energy Project

19/09/2018The Hospital Energy Project

The Hospital Energy Project is an ambitious engineering scheme to replace outdated systems at Oxford University NHS FT’s hospitals and redu... more >
Social media's role in health

19/09/2018Social media's role in health

Social media has a massive role to play in health – infection prevention and control in particular, write Brett Mitchell, professor of nurs... more >
Dickson: Hancock finds an NHS in need of digital rebirth

19/09/2018Dickson: Hancock finds an NHS in need of digital rebirth

Niall Dickson, chief executive of the NHS Confederation, takes a look at Matt Hancock's priorities and agenda around workforce, technology and pr... more >
GDEs: Never stop learning

19/09/2018GDEs: Never stop learning

Paul Charnley, director of IT and information at Wirral University Teaching Hospital NHS FT, discusses what his organisation has learnt from bein... more >


Duncan Selbie: A step on the journey to population health

24/01/2018Duncan Selbie: A step on the journey to population health

The NHS plays a part in the country’s wellness – but it’s far from being all that matters. Duncan Selbie, chief executive of Pu... more >
Cutting through the fake news

22/11/2017Cutting through the fake news

In an era of so-called ‘fake news’ growing alongside a renewed focus on reducing stigma around mental health, Paul Farmer, chief exec... more >
Tackling infection prevention locally

04/10/2017Tackling infection prevention locally

Dr Emma Burnett, a lecturer and researcher in infection prevention at the University of Dundee’s School of Nursing and Midwifery and a boar... more >
Scan4Safety: benefits across the whole supply chain

02/10/2017Scan4Safety: benefits across the whole supply chain

NHE interviews Gillian Fox, head of eProcurement (Scan4Safety) programme at NHS Supply Chain. How has the Scan4Safety initiative evolved sin... more >

health service focus

View all News